Literature DB >> 2735226

The pharmacologic activity of complexes and mixtures with copper and salicylates or aminopyrine following oral dosing in rats.

Z Korolkiewicz1, E Hać, I Gagało, P Gorczyca, A Lodzińska.   

Abstract

Cu(II) complexes with salicylates or aminopyrine were administered to rats with local inflammation (acute paw oedema elicited with carrageenan) to determine their anti-inflammatory activity and ulcerogenic effects following oral administration. The complexes were more effective than the parent ligands or appropriate mixtures of these ligands with Cu(II) as anti-inflammatory agents. All complexes indicated low ulcerogenity. The differences in pharmacologic activity between the complexes and mixtures in question are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2735226     DOI: 10.1007/bf01967301

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  9 in total

1.  Evaluation of copper complexes as potential anti-arthritic drugs.

Authors:  J R Sorenson
Journal:  J Pharm Pharmacol       Date:  1977-07       Impact factor: 3.765

2.  Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs.

Authors:  C A WINTER; E A RISLEY; G W NUSS
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

3.  Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate.

Authors:  J R Sorenson; W Hangarter
Journal:  Inflammation       Date:  1977-09       Impact factor: 4.092

Review 4.  The role of copper in inflammatory disorders.

Authors:  A J Lewis
Journal:  Agents Actions       Date:  1984-12

5.  A comparison of the anti-inflammatory effects of copper aspirinate and other copper salts in the rat and guinea pig.

Authors:  A J Lewis
Journal:  Agents Actions       Date:  1978-04

Review 6.  Copper and inflammation--a possible rationale for the pharmacological manipulation of inflammatory disorders.

Authors:  R Milanino; A Conforti; L Franco; M Marrella; G Velo
Journal:  Agents Actions       Date:  1985-09

7.  Dermal copper drugs: the copper bracelet and cu(II) salicylate complexes.

Authors:  W R Walker; S J Beveridge; M W Whitehouse
Journal:  Agents Actions Suppl       Date:  1981

8.  Pharmacologic activities of copper compounds in chronic diseases.

Authors:  J R Sorenson; L W Oberley; R K Crouch; T W Kensler; V Kishore; S W Leuthauser; T D Oberley; A Pezeshk
Journal:  Biol Trace Elem Res       Date:  1983-08       Impact factor: 3.738

9.  Interaction of salicylates and other non-steroidal anti-inflammatory agents in rats as shown by gastro-ulcerogenic and anti-inflammatory activities, and plasma concentrations.

Authors:  T Corell; K M Jensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-09
  9 in total
  2 in total

Review 1.  Is copper pro- or anti-inflammatory? A reconciling view and a novel approach for the use of copper in the control of inflammation.

Authors:  G Berthon
Journal:  Agents Actions       Date:  1993-07

2.  Cupric yersiniabactin is a virulence-associated superoxide dismutase mimic.

Authors:  Kaveri S Chaturvedi; Chia S Hung; Daryl E Giblin; Saki Urushidani; Anthony M Austin; Mary C Dinauer; Jeffrey P Henderson
Journal:  ACS Chem Biol       Date:  2013-12-11       Impact factor: 5.100

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.